首页> 外国专利> Anti-cancer gene therapy by modulating immune or inflammatory response

Anti-cancer gene therapy by modulating immune or inflammatory response

机译:通过调节免疫或炎症反应进行抗癌基因治疗

摘要

Use of a viral vector contg. in its genome a DNA fragment (I) contg. 1 gene encoding all or part of an agent (A) that modulates the immune and/or inflammatory response for the treatment of cancer in mammals is new. (A) can be a cell surface co-stimulatory molecule, a chemokine, a monoclonal antibody against a lymphocyte surface maker, a super antigen characteristic of an infectious organism (bacterium, virus or parasite), a polypeptide with adjuvant activity or esp. a cytokine. Also claimed is the use of a viral vector with positive tropism for cancer cells contg. in its genome a DNA fragment including 1 gene, encoding an agent able to destroy cancer cells, under control of appropriate expression elements, for selective delivery of the agent to cancerous tumours.
机译:继续使用病毒载体。在其基因组中有一个DNA片段(I)续。 1个编码全部或部分调节免疫和/或炎症反应以治疗哺乳动物癌症的试剂(A)的基因是新的。 (A)可以是细胞表面共刺激分子,趋化因子,针对淋巴细胞表面产生剂的单克隆抗体,感染性生物体(细菌,病毒或寄生虫)特有的超抗原,具有佐剂活性或esp的多肽。细胞因子。还要求保护具有正向性的病毒载体在癌细胞中的应用。在其基因组中的DNA片段包括一个基因,该基因片段在适当的表达元件的控制下编码能够破坏癌细胞的试剂,以选择性地将该试剂递送至癌性肿瘤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号